Professor Jonathan Emberson
BA, MSc, PhD
Professor of Medical Statistics and Epidemiology
- MRC Population Health Research Unit Programme Leader
- MSc in Global Health Science Module Lead: Clinical Trials and Meta-Analysis
Jonathan is Professor of Medical Statistics and Epidemiology within the Nuffield Department of Population Health. After graduating in Mathematics in 1998, he studied statistics and epidemiology at MSc and PhD level before joining the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2004.
His main research involves studying the causes and prevention of cardiovascular diseases through the design, conduct and analysis of large-scale observational cohort studies, randomised controlled trials, and individual-participant-data meta-analyses of both types of study. He is the UK Principal Investigator and MRC Population Health Research Unit (MRC-PHRU) Programme Leader for the Mexico City Prospective Study, a blood-based prospective cohort study of 150,000 Mexican adults followed for more than 15 years.
Rare coding variants in CHRNB2 reduce the likelihood of smoking
EMBERSON J. et al, (2023), Nature Genetics
Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP)
HERRINGTON W. et al, (2023), Kidney International Reports
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby PW. et al, (2023)
Diabetes and infectious disease mortality in Mexico City.
Bragg F. et al, (2023), BMJ Open Diabetes Res Care, 11
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK.
Zhou J. et al, (2023), Pharmacoeconomics